Enanta Pharmaceuticals (ENTA) Cash & Equivalents Growth (1y) (2013 - 2026)
Enanta Pharmaceuticals (ENTA) Cash & Equivalents Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
988.88% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
3.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.77% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Enanta Pharmaceuticals |
365.48 Mn |
201.71 Mn |
- |
-41.99% |
| Date | Value |
|---|
| Mar 31, 2026 |
-41.99% |
| Dec 31, 2025 |
-55.62% |
| Sep 30, 2025 |
-13.25% |
| Jun 30, 2025 |
25.26% |
| Mar 31, 2025 |
-5.24% |
| Dec 31, 2024 |
111.23% |
| Sep 30, 2024 |
-56.40% |
| Jun 30, 2024 |
-62.41% |
| Mar 31, 2024 |
-13.17% |
| Dec 31, 2023 |
-5.42% |
| Sep 30, 2023 |
94.09% |
| Jun 30, 2023 |
235.52% |
| Mar 31, 2023 |
78.53% |
| Dec 31, 2022 |
-57.38% |
| Sep 30, 2022 |
-23.10% |
| Jun 30, 2022 |
516.54% |
| Mar 31, 2022 |
-46.85% |
| Dec 31, 2021 |
79.81% |
| Sep 30, 2021 |
-34.34% |
| Jun 30, 2021 |
-95.39% |
